Nov 4, 2021 · Patients with three-vessel coronary artery disease have been found to have better outcomes with coronary-artery bypass grafting (CABG) than with percutaneous coronary …

Aug 21, 2023 · FAME 3 (Fractional Flow Reserve versus Angiography for Multivessel Evaluation) is an investigator-initiated, multicenter, international, randomized trial involving patients with 3 …

Nov 1, 2021 · In FAME 3, William F. Fearon, MD, FACC, and colleagues, randomized 1,500 patients at 48 centers in Europe, North America, Australia and Asia to either FFR-guided PCI …

Dec 22, 2023 · Highlighted text has been updated as of December 22, 2023. The FAME 3 trial demonstrated that FFR-guided PCI using current-generation DES did not meet criteria for …

By incorporating FFR-guided PCI and utilizing the 2nd generation Resolute Integrity stent, FAME 3 aims to demonstrate that FFR-guided PCI is non-inferior to CABG in patients with 3-vessel …

May 17, 2024 · PARIS, France—Among patients with three-vessel disease, contemporary fractional flow reserve (FFR)-guided PCI is more cost-effective compared with CABG surgery …

Sep 19, 2022 · We evaluate the prognostic value of measuring fractional flow reserve (FFR) after percutaneous coronary intervention (post-PCI FFR) and intravascular imaging in patients …

The FAME 3 study will compare in a multicenter, randomized fashion FFR-guided PCI with contemporary drug-eluting stents to CABG in patients with 3-VD.

The FAME 3 (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation 3) trial compared FFR-guided PCI with CABG in patients with angiographic 3-vessel CAD. In this …

Nov 4, 2021 · In the FAME 3 study, presented at TCT 2021 and published simultaneously in the New England Journal of Medicine, patients treated with FFR-guided PCI had a higher rate of …